You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
隴神戎發(300534.SZ):擬以3.26億元收購普安製藥70%的股權
格隆匯 09-25 17:47

格隆匯9月25日丨隴神戎發(300534.SZ)公佈,公司擬通過支付現金方式收購甘肅藥業集團和甘肅農墾集團持有的普安製藥70%的股權,此次交易合計對價為32608.03萬元。

此次交易前,公司從事的主要業務為醫藥產品、醫療產品、保健衞生產品的研究開發;中成藥、保健食品、原料藥的生產和銷售。此次公司擬收購普安製藥,屬於公司在原有業務領域的進一步擴展,豐富了公司產品品種。同時,依託公司現有的產品與生產體系,充分發揮公司的管理優勢、品牌優勢,憑藉主打產品元胡止痛滴丸積累的推廣經驗和銷售渠道,整合普安製藥的產品線與營銷體系,實現併購協同效應,提高公司銷售收入,提升公司產品的市場佔有率與可持續發展能力,有利於進一步增強公司主營業務的市場競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account